Novo Nordisk
NVO
NVO
550 hedge funds and large institutions have $7.99B invested in Novo Nordisk in 2018 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 162 increasing their positions, 196 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less first-time investments, than exits
New positions opened: 74 | Existing positions closed: 77
1% less funds holding
Funds holding: 558 → 550 (-8)
17% less repeat investments, than reductions
Existing positions increased: 162 | Existing positions reduced: 196
Holders
550
Holding in Top 10
12
Calls
$78.1M
Puts
$32.3M
Top Buyers
| 1 | +$195M | |
| 2 | +$100M | |
| 3 | +$49.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.1M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$18.8M |
Top Sellers
| 1 | -$46.2M | |
| 2 | -$30.9M | |
| 3 | -$25.9M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$22.6M |
| 5 |
LIM
Lagoda Investment Management
New York
|
-$15.4M |